Azala

Small-Molecule Tyrosinase Inhibitors for Treatment of Hyperpigmentation

Gorde:
Argitaratua izan da:Molecules vol. 30, no. 4 (2025), p. 788
Egile nagusia: Ni, Xinhua
Beste egile batzuk: Luo, Xinyu, Jiang, Xiaoying, Chen, Wenchao, Bai, Renren
Argitaratua:
MDPI AG
Gaiak:
Crystal structure
Physiology
Copper
Medical prognosis
Metastasis
Melanoma
Oxidation
Enzymes
Kinases
Radiation therapy
Biosynthesis
Skin cancer
Proteins
Molecules
Sarrera elektronikoa:Citation/Abstract
Full Text + Graphics
Full Text - PDF
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
Laburpena:Increasing attention is being focused on skin health currently, especially the excessive deposition of melanin in the skin. Tyrosinase, the rate-limiting enzyme in melanin biosynthesis, is a crucial enzyme in melanin synthesis. However, existing tyrosinase inhibitors pose some degree of toxicity to humans. Therefore, the development of more efficient and low-toxicity tyrosinase inhibitors is urgently needed. This review briefly depicts the melanin biosynthesis process and the crystal structure and catalytic mechanism of tyrosinase. The latest research progress regarding small-molecule tyrosinase inhibitors is also reviewed. Moreover, the structure–function relationships are analyzed and summarized. This is expected to provide new and more scientific insights to enable researchers to explore safer and more potent tyrosinase inhibitors.
ISSN:1420-3049
DOI:10.3390/molecules30040788
Baliabidea:Health & Medical Collection